SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-019339
Filing Date
2024-07-08
Accepted
2024-07-08 16:15:11
Documents
1
Period of Report
2024-07-03

Document Format Files

Seq Description Document Type Size
1 form4-07082024_040701.html 4  
1 form4-07082024_040701.xml 4 3324
  Complete submission text file 0001415889-24-019339.txt   4999
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005 415-798-8589
Tempest Therapeutics, Inc. (Issuer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O IMMUNE DESIGN CORP. 1616 EASTLAKE AVE. E, SUITE 310 SEATTLE WA 98102
Business Address
Brady Stephen R (Reporting) CIK: 0001606241 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35890 | Film No.: 241104886